Integrated Biopharma, Inc.
INBP
$0.31
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -166.42% | 114.39% | 130.37% | 538.98% | 570.00% |
| Total Depreciation and Amortization | 3.15% | 0.00% | 5.30% | 7.38% | 6.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 514.39% | 81.69% | 1,488.89% | 208.54% | 20.87% |
| Change in Net Operating Assets | 54.73% | -161.07% | 79.40% | -117.64% | 44.51% |
| Cash from Operations | 417.74% | -62.51% | 111.00% | -49.96% | 84.32% |
| Capital Expenditure | 106.85% | 66.38% | -20.83% | -47.37% | -711.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 97.26% | 66.38% | -20.83% | -47.37% | -758.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 90.91% | 100.00% | 100.00% | 30.00% | -10.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 709.09% | 100.00% | 263.64% | -333.33% | -10.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 290.67% | -61.18% | 110.20% | -53.52% | 71.72% |